This episode of Industry Focus is brought to you by Casper, a sleep brand that continues to revolutionize its line of products to create an exceptionally comfortable sleep experience one night at a time.

Get $50 off select mattresses by visiting Casper.com slash fool and using promo code fool at

checkout.

Welcome to Industry Focus, the podcast that dives into a different sector of the stock

market every day.

It's Wednesday, January 10th.

I'm your host Christine Hargis, and I'm reporting from San Francisco this week

from the J.P. Morgan Healthcare Conference,

colloquially known as either the Super Bowl of biotech or the Woodstock of biotech depending on which high school stereotype you were.

You might think that there'd be a heck of a lot more hippie types here in SF, but after attending an event two nights go called burgers and beers in which about 200 men and 10 women packed into a

single bar to watch football I'm really not so sure.

Anyway, today's episode is going to feature clips from interviews with various CEOs of

biotechs that presented at the conference.

The first interview you'll hear is with Barry Green, the CEO of Al Nylum.

Barry, thank you so much for joining me.

Christine, thanks for having us.

So I would love to set the stage for our chat by discussing first a little bit about the scientific

platform that you guys are working with which is RNAI. So can you give us a

little bit of backgrounds on what that is, how it works? Yeah, absolutely. So

El Nylon, which is now 15 years old and on the cusp of becoming a commercial stage company,

was actually founded on this breakthrough discovery in biology called RNA interference,

which is a natural process in all of our cells that manipulates the genome.

...